MARIGO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.986
EU - Europa 1.428
AS - Asia 1.143
AF - Africa 315
SA - Sud America 289
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 14
Totale 6.206
Nazione #
US - Stati Uniti d'America 2.821
IT - Italia 649
SG - Singapore 338
CN - Cina 259
BR - Brasile 193
HK - Hong Kong 163
DE - Germania 96
FI - Finlandia 88
NL - Olanda 81
PL - Polonia 52
RU - Federazione Russa 43
FR - Francia 42
GB - Regno Unito 38
KR - Corea 37
IN - India 35
VN - Vietnam 32
UA - Ucraina 31
SE - Svezia 29
AT - Austria 20
CH - Svizzera 19
AZ - Azerbaigian 16
MX - Messico 16
AE - Emirati Arabi Uniti 15
CO - Colombia 15
ES - Italia 15
IQ - Iraq 15
PS - Palestinian Territory 15
AR - Argentina 14
BE - Belgio 14
IE - Irlanda 14
JO - Giordania 14
RO - Romania 14
TT - Trinidad e Tobago 14
SA - Arabia Saudita 13
AO - Angola 12
BF - Burkina Faso 12
CZ - Repubblica Ceca 12
EC - Ecuador 12
MA - Marocco 12
TZ - Tanzania 12
UZ - Uzbekistan 12
CI - Costa d'Avorio 11
DK - Danimarca 11
EE - Estonia 11
IS - Islanda 11
MW - Malawi 11
ZM - Zambia 11
BY - Bielorussia 10
CA - Canada 10
CL - Cile 10
CU - Cuba 10
GR - Grecia 10
GT - Guatemala 10
HR - Croazia 10
IL - Israele 10
JM - Giamaica 10
NP - Nepal 10
PE - Perù 10
TN - Tunisia 10
UY - Uruguay 10
BG - Bulgaria 9
GA - Gabon 9
HN - Honduras 9
LV - Lettonia 9
MN - Mongolia 9
NZ - Nuova Zelanda 9
PK - Pakistan 9
PY - Paraguay 9
SN - Senegal 9
TL - Timor Orientale 9
TR - Turchia 9
AL - Albania 8
AM - Armenia 8
AU - Australia 8
BJ - Benin 8
CG - Congo 8
CR - Costa Rica 8
DZ - Algeria 8
EG - Egitto 8
GH - Ghana 8
GM - Gambi 8
GP - Guadalupe 8
JP - Giappone 8
KH - Cambogia 8
LA - Repubblica Popolare Democratica del Laos 8
MK - Macedonia 8
MU - Mauritius 8
MZ - Mozambico 8
PH - Filippine 8
RS - Serbia 8
SD - Sudan 8
TW - Taiwan 8
XK - ???statistics.table.value.countryCode.XK??? 8
YT - Mayotte 8
AD - Andorra 7
BA - Bosnia-Erzegovina 7
BB - Barbados 7
BO - Bolivia 7
BS - Bahamas 7
BW - Botswana 7
Totale 5.875
Città #
Fairfield 395
Ashburn 256
Woodbridge 238
Singapore 221
Houston 206
Chandler 202
Ann Arbor 160
Hong Kong 158
Seattle 154
Cambridge 126
Wilmington 110
Santa Clara 109
Jacksonville 95
Beijing 83
Boardman 60
San Diego 58
Princeton 55
Milan 41
Bytom 39
Padova 39
Hefei 35
Los Angeles 34
Helsinki 33
Medford 29
Roxbury 29
Des Moines 28
Munich 28
Seoul 28
São Paulo 19
Chicago 18
Lappeenranta 18
Ogden 16
Pune 16
Nuremberg 15
Amman 14
Rome 14
Baku 13
Dublin 13
Florence 13
Ho Chi Minh City 13
Turku 13
Council Bluffs 12
Vienna 12
Buffalo 11
Dar es Salaam 11
Lusaka 11
Nanjing 11
Ouagadougou 11
Salt Lake City 11
Abidjan 10
London 10
Verona 10
Aprilia 9
Dakar 9
Dili 9
Luanda 9
New York 9
Reykjavik 9
Tallinn 9
Tashkent 9
Villafranca Padovana 9
Falkenstein 8
Guatemala City 8
Kingston 8
Libreville 8
Lilongwe 8
Montevideo 8
Phnom Penh 8
San Francisco 8
Andorra la Vella 7
Bridgetown 7
Brooklyn 7
Brussels 7
Conakry 7
Dallas 7
Havana 7
Hebei 7
Jeddah 7
Kharkiv 7
Kigali 7
Lima 7
Ljubljana 7
Maputo 7
Minsk 7
Tbilisi 7
Turin 7
Ulan Bator 7
Bamako 6
Cagliari 6
Cotonou 6
Hanoi 6
Harare 6
Kampala 6
Nairobi 6
Nanchang 6
Nouakchott 6
Panama City 6
Quito 6
Riga 6
San José 6
Totale 3.713
Nome #
Il programma tollerogenico delle cellule soppressorie di origine mieloide dipende dal fattore di trascrizione C/EBPbeta 738
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 245
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 205
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 200
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 191
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. 161
Myeloid-derived suppressor cell role in tumor-related inflammation 155
Poly(L-glutamic acid)-co-poly(ethylene glycol) block copolymers for protein conjugation 155
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. 146
Myeloid-derived suppressor cell heterogeneity in human cancers. 145
The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment 141
Role of arginine metabolism in immunity and immunopathology. 141
Complexity and challenges in defining myeloid-derived suppressor cells. 140
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 139
4PD functionalized dendrimers: A flexible tool for in vivo gene silencing of tumor-educated myeloid cells 138
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells 136
Derangement of immune responses by myeloid suppressor cells 134
Myeloid-derived suppressor cell heterogeneity and subset definition 132
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival 132
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention 129
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules 129
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPbeta Transcription Factor. 127
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice 126
GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors 124
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma 123
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer 121
Therapeutic effectiveness of recombinant cancer vaccines is associated with prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes 109
Tumors induce a subset of inflammatory moncytes with immunosuppressive activity on CD8+ T cells. 106
The endless saga of monocyte diversity 99
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade 94
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF 93
Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer 89
Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules 88
Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations 86
Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells 86
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 80
The immunomodulatory properties of mesenchymal stem cells 79
Bioinspired orthogonal-shaped protein-biometal nanocrystals enable oral protein absorption 78
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade 76
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment 75
Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant 75
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination 74
Protamine nanocapsules as carriers for oral peptide delivery 72
Potentantimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 71
Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery 70
Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers 68
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma 68
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms 57
Peptide‐Drug Conjugate for Therapeutic Reprogramming of Tumor‐Associated Macrophages in Breast Cancer 39
Totale 6.285
Categoria #
all - tutte 21.395
article - articoli 19.982
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 77 30 13 8 43 52 69 44 7
2021/2022729 9 52 108 23 22 14 194 36 14 11 130 116
2022/2023490 84 66 13 44 75 63 7 24 59 6 36 13
2023/2024588 33 33 55 57 41 71 78 44 41 33 63 39
2024/20251.435 29 112 97 56 218 86 93 134 94 62 194 260
2025/20261.676 222 383 721 350 0 0 0 0 0 0 0 0
Totale 6.285